AusCP-CTN team has successfully recruited >1,700 kids with CP across 15 national clinical trials

21 February 2022

The AusCP-CTN CRE team builds on our strong track records undertaking RCTs of interventions for infants/children with CP and their families. The team has conducted more randomised controlled trials in cerebral palsy than any other group worldwide, and are the only group poised to aggregate trial findings with prospective follow-up to determine long-term school and employment outcomes of children with CP who have been identified early and received early neuroprotection and/or early neuro rehabilitation. Internationally the group is known for creating far-reaching new knowledge that fundamental changes practice and policy including: early diagnosis, early intervention, MRI standards and genetic causal paths. Our links to CP registers will enable us to test the changes in neurodevelopment and school readiness outcomes for children with CP identified earlier, who received neuroprotectants & earlier neuro-rehabilitation.

Find out more about our  projects. projects

Since 2017, the AusCP-CTN team have collaborated with medical researchers, medical clinicians and allied health workers, and have successfully recruited over 1,700 families with children with CP, across 15 multi-site randomised clinical trials. In particular, children identified at high risk of CP are being offered one of four early intervention trials (supported by NHMRC and Cerebral Palsy Alliance) – click below for most recent project updates:

  • GAME: Goal directed Active Motor intervention with Environmental Enrichment
  • PACT & Early PACT: Parenting Acceptance and Commitment Therapy, and Early PACT for children under 3 years of age
  • REACH: Rehabilitation Early for Congenital Hemiplegia
  • VISIBLE: Vision intervention for Seeing Impaired babies through Learning and Enrichment
  • LEAP-CP Indigenous: learning through Everyday Activities with Parents of Indigenous infants identified as likely CP

In addition to our early clinical trials we have prospective cohort surveillance studies for babies born at term (NEBO), and born preterm (PREBO).

For more information about our current projects include: